Ivey Business School (Canada)
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
Strategizing at Monarchia Matt International (MMI)
Michael J. Rouse; Jordan MitchellCase IVEY-9B07M014-EEntrepreneurship, StrategyAs of late 2004, the chief executive officer (CEO) of New York-based wine distributor Monarchia Matt International (MMI) is looking at his portfolio of wines and wondering what advantage Hungarian wine could provide in becoming a powerful niche player in the highly fragmented and complicated U.S. wine industry. The CEO is cognizant of Hungarian wine's reputation in the United States as an inexpensive, mass-quantity produced and low quality drink....Starting at €8.20
-
American Constructors Inc.: World Outreach Expansion Project
Kenneth J. Klassen; Leanne MieleCase IVEY-9B10D016-EService and Operations ManagementThe project manager for American Constructors Inc. (ACI) sat down with his team on September 24, 2009, to evaluate the progress of its building expansion project in Murfreesboro, Tennessee. The team had been working on the World Outreach Church expansionStarting at €8.20
-
eRecon Software Development at Hospital Corporation of America
Kenneth J. Klassen; Leanne RayoCase IVEY-9B16D002-EService and Operations ManagementOn July 28, 2014, the eRecon technical team at Physician Services Group in Hospital Corporation of America, gathered in the main conference room just as it did every Monday morning. The goal of the meeting was to review the project plan and update task completion for the team's two-year undertaking — a six-phase, in-house development of a custom, web-based accounting software called eRecon. As the team members worked through each task and updated...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M014-EStrategyPfizer Inc., the largest research-based drug company in the world, was faced with multiple challenges, including fierce court battles with generic drug companies over the patents of Lipitor, reduced productivity from research and development, and a changing external health care environment globally, with growing importance of emerging markets. These challenges were set within a business environment characterized by multi-level change and uncertai...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (B) The Wyeth Acquisition
Michael J. Rouse; Chander SehgalCase IVEY-9B10M053-EStrategyThis supplement to Change at Pfizer: Jeff Kindler (A) deals with Pfizer’s 2009 acquisition of Wyeth — the first mega-acquisition since the world economic crisis.Starting at €5.74